Short answer

When designing implantable medical devices, consider incorporating bioactive coatings, and conduct research to determine the optimal concentration and delivery method for therapeutic agents to maximize integration and regeneration.

Field
Innovation & Design
Source
BioMed Research International (2015)
Method
Experimental, Animal Study
Sample
6 implants per group (total 24 implants across 2 animals)
Evidence
Strong effect

Applying specific concentrations of recombinant human bone morphogenetic protein-2 (rhBMP-2) to sandblasted and acid-etched (SLA) titanium dental implants demonstrably improves bone regeneration and osseointegration in bone defects. This innovation & design research insight is drawn from a 2015 study published in BioMed Research International. Using Experimental, animal study with 6 implants per group (total 24 implants across 2 animals), researchers explored how this design variable affects real-world outcomes. The key design takeaway: When designing implantable medical devices, consider incorporating bioactive coatings, and conduct research to determine the optimal concentration and delivery method for therapeutic agents to maximize integration and regeneration.

Study
Innovation & DesignHigh ImpactStrong effect

rhBMP-2 Concentration on SLA Implants Significantly Enhances Osseointegration

Applying specific concentrations of recombinant human bone morphogenetic protein-2 (rhBMP-2) to sandblasted and acid-etched (SLA) titanium dental implants demonstrably improves bone regeneration and osseointegration in bone defects.

BioMed Research International · 2015

01

Key Findings

  • 01Implants coated with 0.5 mg/mL and 1.0 mg/mL rhBMP-2 showed significantly greater vertical bone height, bone-to-implant contact, and bone volume compared to the control group.
  • 02The highest implant stability quotient (ISQ) values were observed in the group treated with 1.0 mg/mL rhBMP-2.
02

Application

Design takeaway

When designing implantable medical devices, consider incorporating bioactive coatings, and conduct research to determine the optimal concentration and delivery method for therapeutic agents to maximize integration and regeneration.

How to apply

Explore the use of growth factors or other biomolecules as coatings for implantable devices to promote tissue integration and regeneration. Carefully research and test different concentrations and delivery mechanisms.

Project actions

  • 01When researching biomaterials, look for studies that investigate how surface treatments affect biological responses.
  • 02Consider how different concentrations of active agents might influence the performance of a designed product.
03

Method & Evidence

AimTo determine the optimal concentration of rhBMP-2 for enhancing bone regeneration and osseointegration on SLA titanium implant surfaces within a bone defect model.
MethodExperimental, Animal Study
ProcedureSLA titanium implants were coated with varying concentrations of rhBMP-2 (0.1, 0.5, and 1 mg/mL). These were then placed into bone defects in beagle dogs. Control implants received no rhBMP-2. After 8 weeks, implant stability, vertical bone height, bone-to-implant contact ratio, and bone volume were measured and compared across groups.
Sample6 implants per group (total 24 implants across 2 animals)
ContextBiomaterials, Dental Implantology, Regenerative Medicine

Variables

IVConcentration of rhBMP-2 on implant surface.
DVImplant stability quotient (ISQ), vertical bone height (VBH), bone-to-implant contact ratio (BIC), bone volume (BV).
CVImplant surface treatment (SLA), defect type, animal model, assessment time point (8 weeks).
04

Strengths & Limitations

Strengths

  • +Utilized a split-mouth design, which reduces variability by using both treated and control implants within the same animal.
  • +Quantified multiple biological and mechanical indicators of osseointegration.

Limitations

The study was conducted on dogs, so human results might differ. It only looked at 8 weeks, so long-term effects are unknown.

Reliability & validity

The use of multiple quantitative measures (ISQ, VBH, BIC, BV) and a controlled experimental design with a split-mouth approach enhances the study's validity. Reliability would depend on the consistency of the rhBMP-2 coating process and measurement techniques.

Think critically

What are the potential risks or side effects associated with using growth factors like rhBMP-2 in implantable devices, and how might these be mitigated in a design?

05

Design Principles

"Bioactive surface functionalization can enhance the biological performance of implantable devices."

This research offers a pathway to enhance the success rate and longevity of dental implants by leveraging biomaterials to actively promote bone healing. For designers, it highlights the potential of surface treatments and bioactive coatings to influence biological outcomes, moving beyond purely mechanical or material properties.

06

What This Means for Your Design

Adding a special protein (rhBMP-2) to dental implants makes them integrate better with the jawbone, especially at higher doses.

How to use in your project

  • 1.Use this study to justify the selection of a biomaterial or surface treatment that aims to promote tissue integration in your design project.
07

Add to My Project

08

Quick Cite

Paragraph starter

The research by Kim et al. (2015) demonstrated that coating titanium dental implants with rhBMP-2 at concentrations of 0.5 mg/mL and 1.0 mg/mL significantly enhanced bone regeneration and osseointegration in a canine model, suggesting that bioactive surface functionalization is a viable strategy for improving implant performance.

09

Source

BioMed Research International

Effects of rhBMP-2 on Sandblasted and Acid Etched Titanium Implant Surfaces on Bone Regeneration and Osseointegration: Spilt-Mouth Designed Pilot Study

journal · 2015

View source

Questions About This Research

What does the research say about rhbmp-2 concentration on sla implants significantly enhances osseointegration?
When designing implantable medical devices, consider incorporating bioactive coatings, and conduct research to determine the optimal concentration and delivery method for therapeutic agents to maximize integration and regeneration. Evidence: BioMed Research International (2015).
Why does "rhBMP-2 Concentration on SLA Implants Significantly Enhances Osseointegration" matter for design?
This research offers a pathway to enhance the success rate and longevity of dental implants by leveraging biomaterials to actively promote bone healing. For designers, it highlights the potential of surface treatments and bioactive coatings to influence biological outcomes, moving beyond purely mechanical or material properties.
How can designers apply this research?
When designing implantable medical devices, consider incorporating bioactive coatings, and conduct research to determine the optimal concentration and delivery method for therapeutic agents to maximize integration and regeneration.
What were the main findings?
Implants coated with 0.5 mg/mL and 1.0 mg/mL rhBMP-2 showed significantly greater vertical bone height, bone-to-implant contact, and bone volume compared to the control group.. The highest implant stability quotient (ISQ) values were observed in the group treated with 1.0 mg/mL rhBMP-2.
What research method was used?
Experimental, Animal Study with 6 implants per group (total 24 implants across 2 animals).
How strong is the evidence?
Evidence strength is rated Strong effect, based on a 2015 journal from BioMed Research International.
What should I do differently in my next project?
Explore the use of growth factors or other biomolecules as coatings for implantable devices to promote tissue integration and regeneration. Carefully research and test different concentrations and delivery mechanisms.
What are the limitations?
This was a pilot study using a specific animal model; results may vary in human clinical applications. The long-term effects of rhBMP-2 were not assessed.